Analyst consensus rating
Cardiol Therapeutics Analyst Rating: Strong Buy
Direct answer
Cardiol Therapeutics's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.46.
Forecast evidence checked November 8, 2026.
Get free Cardiol Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.00
- Average price target
- $8.46
- High price target
- $10.93
- Low price target
- $5.01
- Low target gap
- +403.2%
- Target upside
- +750.1%
- High target gap
- +998.3%
- Target range width
- 595.1%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- November 8, 2026
- Valid through
- November 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cardiol Therapeutics?
Cardiol Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $8.46.
How far are Cardiol Therapeutics's low and high targets from the recorded price?
The low target implies +403.2%, while the high target implies +998.3%.
How many analysts are included in Cardiol Therapeutics's consensus?
The verified consensus includes 5 analysts.
How is Cardiol Therapeutics's target upside or downside calculated?
The average target of $8.46 is divided by the recorded price of $1.00, then one is subtracted to produce +750.1%. This does not guarantee a future return.
When was Cardiol Therapeutics's analyst forecast verified?
The data was verified on 2026-11-08. The dataset is valid through 2026-11-15.